Avery R A, Denunzio T M, Craig D B
Hematology Oncology Service, Eisenhower Army Medical Center, Fort Gordon, Georgia 30905, USA.
Am J Hematol. 1998 Jun;58(2):148-9. doi: 10.1002/(sici)1096-8652(199806)58:2<148::aid-ajh12>3.0.co;2-7.
We present a case of a patient who is HIV positive and developed both thrombotic thrombocytopenia purpura and visceral Kaposi's sarcoma (KS) with hemorrhage. This case presents a difficult management problem in that the patient's bleeding originated from KS lesions and did not quickly abate with plasmapheresis therapy despite both clinical and laboratory improvement after 2-4 days. Chemotherapy was initiated on day 13 and the patient's condition improved markedly afterward. We believe the addition of chemotherapy to plasmapheresis hastened the improvement of our patient's thrombotic thrombocytopenic purpura (TTP) and KS-related bleeding. Therefore, under similar conditions, we recommend combining plasmapheresis and chemotherapy at the onset of therapy.
我们报告一例HIV阳性患者,该患者同时发生了血栓性血小板减少性紫癜和伴有出血的内脏卡波西肉瘤(KS)。该病例存在一个棘手的管理问题,即患者的出血源自KS病灶,尽管在2 - 4天后临床和实验室指标有所改善,但血浆置换治疗后出血并未迅速缓解。在第13天开始化疗,此后患者的病情显著改善。我们认为,在血浆置换基础上加用化疗加速了患者血栓性血小板减少性紫癜(TTP)和KS相关出血的改善。因此,在类似情况下,我们建议在治疗开始时联合应用血浆置换和化疗。